Our results highlight six inflammatory serum proteins that differ between NAFL and NASH-patients (ST1A1, ADA, Flt3L, EN-RAGE, IL-6, IL-18). This evidence concerns the gene FLT3LG and metabolic dysfunction-associated steatohepatitis.